Sunday, 20 January 2019
Latest news
Main » Is Celgene Corporation (NASDAQ:CELG) a Long Term Growth Play?

Is Celgene Corporation (NASDAQ:CELG) a Long Term Growth Play?

17 May 2018

Taking a look at the current stock price for Celgene Corporation (NASDAQ:CELG), we could notice that the shares are trading close to the $85.31 level. It closed at $4.14 lastly. Since May 16, 2017 CELG has declined 31.28% and is downtrending.

Psagot Investment House Ltd increased its stake in Celgene (Celg) (CELG) by 33.47% based on its latest 2017Q4 regulatory filing with the SEC. Renaissance Investment Group Llc bought 8,143 shares as the company's stock declined 19.30% with the market. Quantitative Systematic Strategies LLC now owns 17,793 shares of the biopharmaceutical company's stock worth $1,587,000 after buying an additional 15,508 shares during the last quarter. Celgene now has $59.53 billion valuation. The stock price decreased -25.46% in three months and dipped -22.25% for the last six months trading period. The target implies a 87.79% spike from where the shares are now trading. It has underperformed by 42.83% the S&P500. Therefore 57% are positive.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on July, 26. The stock presently has an average rating of "Buy" and an average target price of $123.98. On Wednesday, October 5 the stock rating was maintained by Jefferies with "Buy". Stifel Nicolaus has "Buy" rating and $149.0 target. Piper Jaffray maintained the shares of CELG in report on Thursday, January 18 with "Hold" rating. The firm has "Buy" rating given on Monday, January 8 by BMO Capital Markets.

Among 21 analysts covering EnLink Midstream LLC (NYSE:ENLC), 4 have Buy rating, 3 Sell and 14 Hold.

The counter witnessed a trading volume of 4.59 million shares versus an average volume of 1.45 million shares during last trading session. On Monday, March 12 LOUGHLIN JAMES J sold $851,093 worth of Celgene Corporation (NASDAQ:CELG) or 9,250 shares. Also, Director Ernest Mario sold 13,370 shares of the firm's stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $94.49, for a total value of $1,263,331.30. The titles are as follows: "Celgene And Otezla Are Cracking" brought out on May 14, 2018, "Celgene Starts the Year With a Bang" on May 14, 2018, "Hagens Berman Reminds Investors in Celgene Corporation (CELG) of the May 29, 2018 Securities Class Action Lead ..." with a publish date: May 16, 2018, "Generic Revlimid Could Sink Celgene" and the last "My 2 Cents On The Ozanimod Saga" with publication date: May 15, 2018.

Short interest or otherwise called the percentage of a stock's tradable shares now being shorted is another data that investors use to get a handle on sentiment. It has change of 0.34, from 2017Q3's 1.17. It fall, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds amassed stakes and 411 increased stakes. Its up 44.72% from 2.55 million shares previously.

The S&P 500 rose 0.3% at 10:20 AM in NY and the Nasdaq Composite index added 0.62%. Eads & Heald Counsel reported 9,301 shares. The SI to POSTNL NV ORDINARY SHARES NETHERLANDS's float is 0.87%.

For more Celgene Corporation (NASDAQ:CELG) news brought out briefly go to:,,, or DekaBank Deutsche Girozentrale lifted its stake in shares of Celgene by 21.5% during the 1st quarter. Crestpoint Capital Lc invested in 5,100 shares. Westend Limited Liability owns 369,364 shares. Brandywine Global Inv Mgmt Llc has invested 0.29% of its portfolio in Celgene Corporation (NASDAQ:CELG).

The S&P 500 Index climbed as technology shares paced gains after President Donald Trump made a major reversal on an earlier move to block telecom equipment-maker ZTE Corp from its U.S. suppliers. Robeco Institutional Asset Management B.V.'s holdings in Celgene were worth $14,602,000 at the end of the most recent quarter. The Rhode Island-based Newman Dignan & Sheerar Inc has invested 0.4% in Celgene Corporation (NASDAQ:CELG). Strategic Glob Advisors Ltd Co has 5,997 shares. 1,950 were accumulated by Cardinal Capital Mngmt. Banco de Sabadell S.A bought a new position in shares of Celgene during the fourth quarter valued at approximately $1,147,000. It also reduced Spdr Bloomberg Barclays (JNK) stake by 16,556 shares and now owns 82,753 shares. Honeywell Intl Inc Com (NYSE:HON) was raised too. Analyst recommendation for this stock stands at 2.3. EnLink Midstream LLC had 74 analyst reports since August 6, 2015 according to SRatingsIntel. Notwithstanding that, the firm is seeing a foremost top-line progress, with their year-over-year quarterly revenue increasing by 19.40%. On Monday, October 16 the stock rating was maintained by Canaccord Genuity with "Buy". On Monday, January 8 the firm has "Buy" rating given by SunTrust. The company was upgraded on Friday, January 6 by JMP Securities. The rating was maintained by Oppenheimer on Wednesday, June 7 with "Buy". Leerink Swann has "Outperform" rating and $160 target. The rating was downgraded by Cowen & Co on Wednesday, July 20 to "Market Perform".